Adma Biologics Inc Stock Ownership - Who owns Adma Biologics?

Insider buying vs selling

Have Adma Biologics Inc insiders been buying or selling?
Kaitlin M. KestenbergmessinaCOO and SVP Compliance2024-03-312,085$6.60
Adam S. GrossmanPresidentCEO and Interim CFO2024-03-3121,752$6.60
Steve ElmsDirector2024-03-19411,829$6.08
Steve ElmsDirector2024-03-1849,887$6.01
Steve ElmsDirector2024-03-15183,008$6.01
Steve ElmsDirector2024-03-14448,276$6.05
Steve ElmsDirector2024-03-13407,000$6.21
Adam S. GrossmanPresident and CEO2024-03-0728,763$6.16
Brian LenzEVP CFO2024-03-0716,965$6.16
Adam S. GrossmanPresident and CEO2024-03-0655,003$6.12

1 of 5

ADMA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADMA insiders and whales buy or sell their stock.

ADMA Shareholders

What type of owners hold Adma Biologics Inc stock?
Blackrock Inc7.85%18,199,277$196.19MInstitution
Perceptive Advisors LLC5.72%13,262,375$142.97MInsider
Divestiture Trust Biotest5.56%12,886,740$138.92MInsider
Vanguard Group Inc5.47%12,689,394$136.79MInstitution
State Street Corp4.55%10,553,353$113.77MInstitution
Nuveen Asset Management LLC4.51%10,461,376$112.77MInstitution
Ag Biotest4.36%10,109,534$108.98MInsider
Invesco Ltd3.37%7,804,227$84.13MInstitution
American Century Companies Inc3.08%7,128,511$76.85MInstitution
Perceptive Advisors LLC2.78%6,433,369$69.35MInstitution

1 of 3

ADMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADMA75.24%24.19%Net SellingNet Selling
ACAD71.24%28.76%Net SellingNet Selling
NTLA70.20%29.80%Net Selling
AGIO75.61%24.39%Net SellingNet Selling
APGE89.97%10.03%Net Buying

Adma Biologics Stock Ownership FAQ

Who owns Adma Biologics?

Adma Biologics (NASDAQ: ADMA) is owned by 75.24% institutional shareholders, 24.19% Adma Biologics insiders, and 0.58% retail investors. Perceptive Advisors LLC is the largest individual Adma Biologics shareholder, owning 13.26M shares representing 5.72% of the company. Perceptive Advisors LLC's Adma Biologics shares are currently valued at $140.98M.

If you're new to stock investing, here's how to buy Adma Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.